HNOI
HNO International, Inc.
$0.1000
+1.57%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
May 8, 2026
SEC
HNO International entered into a securities purchase agreement with Monroe Street Capital Partners, issuing a $67,500 co
8-K — Impact 7/10
May 1, 2026
SEC
HNO International entered into an Equity Purchase Agreement with Lambda Ventures LLC to sell up to $30M of common stock
8-K — Impact 7/10
Apr 17, 2026
SEC
HNO International raised $175,000 through two convertible note financings with Jefferson Street Capital and Lambda Ventu
8-K — Impact 6/10
Feb 10, 2026
Insider
Owens Donald W gifted 200,000 shares
CEO, President and Secretary
Latest Reports
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Feb 10, 2026 | Owens Donald | G | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 1 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Owens Donald W | CEO, President and Secretary | GIFT | 200,000 | — | — |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 4 bearish, 0 mixed, 0 neutral. Avg impact: 6.8/10.
BEARISH
8-K
7/10
HNO International entered into a securities purchase agreement with Monroe Street Capital Partners,
May 8, 2026
BEARISH
8-K
7/10
HNO International entered into an Equity Purchase Agreement with Lambda Ventures LLC to sell up to $
May 1, 2026
BEARISH
8-K
6/10
HNO International raised $175,000 through two convertible note financings with Jefferson Street Capi
Apr 17, 2026
BEARISH
8-K
7/10
HNO International, Inc. dismissed its auditor Barton CPA, PLLC and appointed Green Growth CPAs as it
Apr 16, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.